Jude Onyia
Chief Scientific Officer at Neurocrine Biosciences Inc (NBIX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $3.5M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jun 2SEC | NBIXNeurocrine Biosciences Inc | Sell Plan | 11,00025,846 held (−30%) | $160.25 | $1.8M | -15.3% |
| May 29SEC | NBIXNeurocrine Biosciences Inc | Sell Plan | 11,00025,846 held (−30%) | $155.53 | $1.7M | -12.7% |
- Sell
Chief Scientific Officer Jude Onyia sold $1.8M of NBIX at $160.25 — cuts the stake by 30%; pre-scheduled 10b5-1 plan sale.
- Sell
Chief Scientific Officer Jude Onyia sold $1.7M of NBIX at $155.53 — cuts the stake by 30%; pre-scheduled 10b5-1 plan sale.